CONMED CORP (CNMD) Fundamental Analysis & Valuation

NYSE:CNMD • US2074101013

Current stock price

38.49 USD
+0.14 (+0.37%)
At close:
38.49 USD
0 (0%)
After Hours:

This CNMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CNMD Profitability Analysis

1.1 Basic Checks

  • CNMD had positive earnings in the past year.
  • In the past year CNMD had a positive cash flow from operations.
  • Of the past 5 years CNMD 4 years were profitable.
  • In the past 5 years CNMD always reported a positive cash flow from operatings.
CNMD Yearly Net Income VS EBIT VS OCF VS FCFCNMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

1.2 Ratios

  • The Return On Assets of CNMD (2.02%) is better than 73.26% of its industry peers.
  • Looking at the Return On Equity, with a value of 4.55%, CNMD is in the better half of the industry, outperforming 75.94% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.23%, CNMD is in the better half of the industry, outperforming 73.26% of the companies in the same industry.
  • CNMD had an Average Return On Invested Capital over the past 3 years of 5.32%. This is below the industry average of 9.12%.
Industry RankSector Rank
ROA 2.02%
ROE 4.55%
ROIC 4.23%
ROA(3y)3.52%
ROA(5y)2.12%
ROE(3y)8.68%
ROE(5y)4.64%
ROIC(3y)5.32%
ROIC(5y)4.74%
CNMD Yearly ROA, ROE, ROICCNMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • The Profit Margin of CNMD (3.42%) is better than 74.33% of its industry peers.
  • CNMD's Profit Margin has improved in the last couple of years.
  • CNMD has a better Operating Margin (8.39%) than 76.47% of its industry peers.
  • In the last couple of years the Operating Margin of CNMD has grown nicely.
  • CNMD has a Gross Margin (54.59%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of CNMD has remained more or less at the same level.
Industry RankSector Rank
OM 8.39%
PM (TTM) 3.42%
GM 54.59%
OM growth 3Y4.64%
OM growth 5Y1.5%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y-0.47%
GM growth 5Y-0.15%
CNMD Yearly Profit, Operating, Gross MarginsCNMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CNMD Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CNMD is destroying value.
  • Compared to 1 year ago, CNMD has more shares outstanding
  • Compared to 5 years ago, CNMD has more shares outstanding
  • CNMD has a better debt/assets ratio than last year.
CNMD Yearly Shares OutstandingCNMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
CNMD Yearly Total Debt VS Total AssetsCNMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 1.83 indicates that CNMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.83, CNMD is in line with its industry, outperforming 55.62% of the companies in the same industry.
  • CNMD has a debt to FCF ratio of 5.53. This is a neutral value as CNMD would need 5.53 years to pay back of all of its debts.
  • The Debt to FCF ratio of CNMD (5.53) is better than 74.87% of its industry peers.
  • CNMD has a Debt/Equity ratio of 0.81. This is a neutral value indicating CNMD is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.81, CNMD is not doing good in the industry: 74.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 5.53
Altman-Z 1.83
ROIC/WACC0.7
WACC6.03%
CNMD Yearly LT Debt VS Equity VS FCFCNMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • CNMD has a Current Ratio of 2.14. This indicates that CNMD is financially healthy and has no problem in meeting its short term obligations.
  • CNMD has a Current ratio (2.14) which is comparable to the rest of the industry.
  • CNMD has a Quick Ratio of 1.01. This is a normal value and indicates that CNMD is financially healthy and should not expect problems in meeting its short term obligations.
  • CNMD's Quick ratio of 1.01 is on the low side compared to the rest of the industry. CNMD is outperformed by 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.01
CNMD Yearly Current Assets VS Current LiabilitesCNMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CNMD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.82% over the past year.
  • Measured over the past years, CNMD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.37% on average per year.
  • Looking at the last year, CNMD shows a small growth in Revenue. The Revenue has grown by 5.18% in the last year.
  • The Revenue has been growing by 9.77% on average over the past years. This is quite good.
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.09% on average over the next years.
  • CNMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.55% yearly.
EPS Next Y-3.63%
EPS Next 2Y4.41%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue Next Year-0.72%
Revenue Next 2Y2.34%
Revenue Next 3Y3.55%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CNMD Yearly Revenue VS EstimatesCNMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CNMD Yearly EPS VS EstimatesCNMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. CNMD Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.35 indicates a reasonable valuation of CNMD.
  • Based on the Price/Earnings ratio, CNMD is valued cheaper than 94.65% of the companies in the same industry.
  • CNMD is valuated cheaply when we compare the Price/Earnings ratio to 27.79, which is the current average of the S&P500 Index.
  • CNMD is valuated reasonably with a Price/Forward Earnings ratio of 8.66.
  • 96.26% of the companies in the same industry are more expensive than CNMD, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 38.88. CNMD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.35
Fwd PE 8.66
CNMD Price Earnings VS Forward Price EarningsCNMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 90.91% of the companies in the same industry are more expensive than CNMD, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CNMD is valued cheaper than 97.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.69
EV/EBITDA 10.28
CNMD Per share dataCNMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • CNMD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.51
EPS Next 2Y4.41%
EPS Next 3Y7.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CNMD Dividend Analysis

5.1 Amount

  • CNMD has a Yearly Dividend Yield of 2.11%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.25, CNMD pays a better dividend. On top of this CNMD pays more dividend than 95.72% of the companies listed in the same industry.
  • CNMD's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.11%

5.2 History

  • The dividend of CNMD has a limited annual growth rate of 0.10%.
  • CNMD has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.1%
Div Incr Years0
Div Non Decr Years0
CNMD Yearly Dividends per shareCNMD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • CNMD pays out 52.59% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • CNMD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP52.59%
EPS Next 2Y4.41%
EPS Next 3Y7.09%
CNMD Yearly Income VS Free CF VS DividendCNMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M
CNMD Dividend Payout.CNMD Dividend Payout, showing the Payout Ratio.CNMD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CNMD Fundamentals: All Metrics, Ratios and Statistics

CONMED CORP

NYSE:CNMD (4/22/2026, 8:16:58 PM)

After market: 38.49 0 (0%)

38.49

+0.14 (+0.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-28
Earnings (Next)04-29
Inst Owners112.85%
Inst Owner Change-0.04%
Ins Owners0.28%
Ins Owner Change1.42%
Market Cap1.16B
Revenue(TTM)1.37B
Net Income(TTM)47.05M
Analysts50.91
Price Target45.08 (17.12%)
Short Float %7.28%
Short Ratio4.7
Dividend
Industry RankSector Rank
Dividend Yield 2.11%
Yearly Dividend0.8
Dividend Growth(5Y)0.1%
DP52.59%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.3%
Min EPS beat(2)0.66%
Max EPS beat(2)5.94%
EPS beat(4)4
Avg EPS beat(4)5.44%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)8
Avg EPS beat(8)5.62%
EPS beat(12)11
Avg EPS beat(12)4.63%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.64%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.25%
Revenue beat(4)1
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-0.84%
Revenue beat(12)3
Avg Revenue beat(12)-0.05%
Revenue beat(16)4
Avg Revenue beat(16)-1.46%
PT rev (1m)-6.75%
PT rev (3m)-8.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.97%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.35%
Valuation
Industry RankSector Rank
PE 8.35
Fwd PE 8.66
P/S 0.84
P/FCF 7.69
P/OCF 6.8
P/B 1.12
P/tB N/A
EV/EBITDA 10.28
EPS(TTM)4.61
EY11.98%
EPS(NY)4.44
Fwd EY11.54%
FCF(TTM)5.01
FCFY13.01%
OCF(TTM)5.66
OCFY14.71%
SpS45.61
BVpS34.28
TBVpS-11.81
PEG (NY)N/A
PEG (5Y)0.51
Graham Number59.6267 (54.91%)
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 4.55%
ROCE 5.74%
ROIC 4.23%
ROICexc 4.31%
ROICexgc 14.63%
OM 8.39%
PM (TTM) 3.42%
GM 54.59%
FCFM 10.98%
ROA(3y)3.52%
ROA(5y)2.12%
ROE(3y)8.68%
ROE(5y)4.64%
ROIC(3y)5.32%
ROIC(5y)4.74%
ROICexc(3y)5.4%
ROICexc(5y)4.81%
ROICexgc(3y)19.18%
ROICexgc(5y)17.21%
ROCE(3y)7.22%
ROCE(5y)6.44%
ROICexgc growth 3Y7.2%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y14.69%
ROICexc growth 5Y5.99%
OM growth 3Y4.64%
OM growth 5Y1.5%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y-0.47%
GM growth 5Y-0.15%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 5.53
Debt/EBITDA 4.4
Cap/Depr 26.66%
Cap/Sales 1.44%
Interest Coverage 4.54
Cash Conversion 90.02%
Profit Quality 320.65%
Current Ratio 2.14
Quick Ratio 1.01
Altman-Z 1.83
F-Score5
WACC6.03%
ROIC/WACC0.7
Cap/Depr(3y)23.78%
Cap/Depr(5y)24.75%
Cap/Sales(3y)1.32%
Cap/Sales(5y)1.51%
Profit Quality(3y)200.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
EPS Next Y-3.63%
EPS Next 2Y4.41%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%
Revenue Next Year-0.72%
Revenue Next 2Y2.34%
Revenue Next 3Y3.55%
Revenue Next 5YN/A
EBIT growth 1Y-44.98%
EBIT growth 3Y14.64%
EBIT growth 5Y11.42%
EBIT Next Year26.75%
EBIT Next 3Y14.3%
EBIT Next 5YN/A
FCF growth 1Y-1.95%
FCF growth 3Y135.18%
FCF growth 5Y23.98%
OCF growth 1Y2.23%
OCF growth 3Y72.25%
OCF growth 5Y21.49%

CONMED CORP / CNMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CNMD.


Can you provide the valuation status for CONMED CORP?

ChartMill assigns a valuation rating of 7 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.


Can you provide the profitability details for CONMED CORP?

CONMED CORP (CNMD) has a profitability rating of 6 / 10.


How financially healthy is CONMED CORP?

The financial health rating of CONMED CORP (CNMD) is 4 / 10.


How sustainable is the dividend of CONMED CORP (CNMD) stock?

The dividend rating of CONMED CORP (CNMD) is 5 / 10 and the dividend payout ratio is 52.59%.